RHHBY's data on experimental obesity drug, CT-996, disappoints investors on higher incidence of adverse events.

Shares of BFLY gain almost 27% following the announcement of the launch of its latest handheld ultrasound device, Butterfly iQ3, in Europe.

Shares of BFLY gain almost 27% following the announcement of the launch of its latest handheld ultrasound device, Butterfly iQ3, in Europe.

In an unprecedented move to enhance customer satisfaction and encourage loyalty, Apple has announced a remarkable offer for its iPhone 15 and iPhone...

WELL's seniors housing operating portfolio is set to benefit from the aging population and rising healthcare spending. However, high competition is a...

WELL's seniors housing operating portfolio is set to benefit from the aging population and rising healthcare spending. However, high competition is a...

SEVERAL construction firms and agencies from both the private and public sectors in Linden took part in an educational seminar Tuesday, aimed at...

Apple's iPhone 16 launch in China has sparked disappointment over lack of AI features, amid growing competition from Huawei.

ADI is benefiting from a strong portfolio and expanding partnerships amid macro headwinds and stiff competition.

ADI is benefiting from a strong portfolio and expanding partnerships amid macro headwinds and stiff competition.